Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19.

Wang, Tao; Chen, Ruchong; Liu, Chunli; Liang, Wenhua; Guan, Weijie; Tang, Ruidi; Tang, Chunli; Zhang, Nuofu; Zhong, Nanshan; Li, Shiyue

Wang, Tao; Chen, Ruchong; Liu, Chunli; Liang, Wenhua; Guan, Weijie; Tang, Ruidi; Tang, Chunli; Zhang, Nuofu; Zhong, Nanshan; Li, Shiyue.

Wang T; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Chen R; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Liu C; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Liang W; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Guan W; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Tang R; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Tang C; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Zhang N; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Zhong N; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China.
Li S; National Clinical Research Centre for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510120, China. Electronic address: lishiyue@188.com.

Lancet Haematol ; 7(5): e362-e363, 2020 05.

Artículo en Inglés | MEDLINE | ID: covidwho-45972

Asunto(s)

Betacoronavirus; Infecciones por Coronavirus/complicaciones; Neumonía Viral/complicaciones; Tromboembolia Venosa/prevención & control; Anticoagulantes/uso terapéutico; Atención; COVID-19; Humanos; Pandemias; Factores de Riesgo; SARS-CoV-2; Tromboembolia Venosa/etiología

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Neumonía Viral / Infecciones por Coronavirus / Tromboembolia Venosa / Betacoronavirus Tipo de estudio: Estudio pronóstico Tópicos: Covid persistente Límite: Humanos Idioma: Inglés Revista: Lancet Haematol Año: 2020 Tipo del documento: Artículo País de afiliación: S2352-3026(20)30109-5

Similares

MEDLINE

LILACS

LIS

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google